Blood-brain barrier abnormalities caused by HIV-1 gp120: mechanistic and therapeutic implications.

Blood-brain barrier abnormalities caused by HIV-1 gp120: mechanistic and therapeutic implications.
复制标题

DOI:
10.1100/2012/482575
复制
发表时间:
2012
影响因子:
--
通讯作者:
Strayer DS
Strayer DS
中科院分区:
其他
文献类型:
--
作者:
Louboutin JP;Strayer DS

文献摘要

参考文献

被引文献

相似文献

The blood-brain barrier (BBB) is compromised in many systemic and CNS diseases, including HIV-1 infection of the brain. We studied BBB disruption caused by HIV-1 envelope glycoprotein 120 (gp120) as a model. Exposure to gp120, whether acute [by direct intra-caudate-putamen (CP) injection] or chronic [using SV(gp120), an experimental model of ongoing production of gp120] disrupted the BBB, and led to leakage of vascular contents. Gp120 was directly toxic to brain endothelial cells. Abnormalities of the BBB reflect the activity of matrix metalloproteinases (MMPs). These target laminin and attack the tight junctions between endothelial cells and BBB basal laminae. MMP-2 and MMP-9 were upregulated following gp120-injection. Gp120 reduced laminin and tight junction proteins. Reactive oxygen species (ROS) activate MMPs. Injecting gp120 induced lipid peroxidation. Gene transfer of antioxidant enzymes protected against gp120-induced BBB abnormalities. NMDA upregulates the proform of MMP-9. Using the NMDA receptor (NMDAR-1) inhibitor, memantine, we observed partial protection from gp120-induced BBB injury. Thus, (1) HIV-envelope gp120 disrupts the BBB; (2) this occurs via lesions in brain microvessels, MMP activation and degradation of vascular basement membrane and vascular tight junctions; (3) NMDAR-1 activation plays a role in this BBB injury; and (4) antioxidant gene delivery as well as NMDAR-1 antagonists may protect the BBB.
DOI: 10.1080/13550280490261699
发表时间: 2004-01-01
影响因子: 3.2
作者:
Conant, K;St Hillaire, C;Nath, A
通讯作者: Nath, A
DOI: 10.1016/j.jneuroim.2004.08.022
发表时间: 2004-12-01
影响因子: 3.3
作者:
Ho, WZ;Douglas, SD
通讯作者: Douglas, SD
DOI: 10.1038/sj.gt.3302821
发表时间: 2006-12-01
期刊: GENE THERAPY
影响因子: 5.1
作者:
Agrawal, L.;Louboutin, J-P;Strayer, D. S.
通讯作者: Strayer, D. S.
DOI: 10.1016/s0002-9440(10)65511-3
发表时间: 1999-12-01
影响因子: 6
作者:
Dallasta, LM;Pisarov, LA;Achim, CL
通讯作者: Achim, CL
小麦胚芽凝集素和衰老对大脑区域摄取 HIV-1GP120 的影响
DOI: 10.1016/s0024-3205(99)00221-0
发表时间: 1999-05-28
期刊: LIFE SCIENCES
影响因子: 6.1
作者:
Banks, WA;Ibrahimi, F;Morley, JE
通讯作者: Morley, JE